Browse life science companies in Cambridge, home to one of Europe's leading biotechnology and life science ecosystems.
Robotic automation platform for scalable cell therapy manufacturing
Cellular Origins is a biotechnology company developing robotic automation systems for the industrial-scale manufacture of cell therapies. Its platform uses mobile robotics and automated sterile fluidic interconnection to link existing bioprocess instruments into fully automated, GMP-compliant manufacturing workflows.…
Engineered cell-derived vesicles for targeted RNA and drug delivery
AAB Therapeutics develops programmable nanovesicles from engineered human cell membranes for targeted intracellular drug delivery. The vesicles are designed to carry RNA, small molecules or biologics, using surface targeting molecules and fusogenic proteins to release their cargo into cells. The preclinical company…
UK manufacturer of microtomes, cryostats and tissue sectioning equipment
Bright Instruments is a Huntingdon-based manufacturer and supplier of laboratory sectioning and cryogenic equipment. Its product range includes rotary microtomes, cryostats, sledge microtomes, freezing units and associated accessories used in histopathology, pathology, life science research and industrial testing.…
Plant protein materials replacing plastics and microplastics
Xampla is a Cambridge-based materials innovation company developing plant protein-based alternatives to single-use plastics and synthetic microplastics. Its range of products includes biodegradable coatings, soluble films, edible films, and microcapsules derived from sustainable vegetable proteins such as pea,…
GCP-accredited oncology molecular diagnostics for clinical trials and research
The Cancer Molecular Diagnostics Laboratory is an ISO 15189-accredited molecular diagnostics facility within the University of Cambridge Department of Oncology, jointly funded by CRUK and NIHR. Operating to GCP and GCLP standards, it provides next-generation sequencing, circulating tumour DNA analysis, liquid biopsy…
Molecular modelling and cheminformatics software for drug discovery
Chemical Computing Group is a scientific software company developing molecular modelling and cheminformatics tools for drug discovery. Its flagship software supports structure-based design, molecular docking, pharmacophore screening and simulations involving small molecules, peptides and proteins. Researchers use…
Manufacturer of amino acid analysers, spectrophotometers, and microplate readers
Biochrom is a UK-based manufacturer of analytical laboratory instruments serving clinical, life science, industrial, and educational markets. Its product range includes dedicated amino acid analysers, UV/visible spectrophotometers, microvolume spectrophotometers, colorimeters, and microplate readers and washers. The…
Single-workflow sequencing technology capturing genetic and epigenetic data
biomodal is a Cambridge-based life sciences technology company developing multiomics sequencing solutions that simultaneously capture genetic and epigenetic information from a single DNA sample. Its multiomics platform detects the canonical four DNA bases alongside 5-methylcytosine and 5-hydroxymethylcytosine…
Plasma amino acid biomarkers for multi-cancer risk assessment
Proteotype Diagnostics develops blood tests to support earlier assessment of possible cancer. Its Enlighten test measures patterns of circulating amino acids in plasma and applies machine learning to estimate the likelihood of malignancy across several solid tumour types. It is designed to inform further clinical…
Enzymatic wound debridement therapy derived from maggot biology
SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical maggots that degrades non-viable wound tissue including fibrin, elastin, and collagen to prepare the wound bed for healing. The product is in…
Engineered enzymes for recycling plastics and mixed textiles
Evoralis is a biotechnology company developing enzymes that break down plastics such as polyester, nylon and polyurethane into their chemical building blocks for recycling. The company uses a microfluidic screening platform to test large numbers of enzyme variants rapidly, allowing candidates to be discovered and…
Collaborative AI and multi-omics software for translational research
Vedaly is a scientific software company developing collaborative AI and bioinformatics tools for translational research and biopharmaceutical development. Its platform brings together omics, clinical and experimental data, analysis results, figures and scientific literature in traceable research workflows. It supports…
Semiconductor platform for benchtop gene synthesis
Evonetix is a company developing a semiconductor chip platform for de novo gene synthesis. Its silicon array technology uses thermal control and on-chip error correction to enable accurate, gene-length DNA synthesis at the benchtop, with applications across engineering biology, medicine, agriculture, and materials…
Continuous industrial biocatalysis reactors and enzyme automation
Biozeroc is a Cambridge industrial biotechnology company developing continuous biocatalysis systems for large-scale manufacturing. Its technology combines enzyme immobilisation, reactor hardware and automation to maintain consistent output as enzyme activity declines, allowing industrial enzymes to operate for longer…
AI-driven intron technology to enhance transgene expression
ExpressionEdits is a biotechnology company developing computational tools to improve protein expression from artificial gene constructs. Its Genetic Syntax Engine uses machine learning and biological data to predict optimal intron insertion patterns within transgenes, increasing protein production levels in mammalian…
AI-driven neural data platform for bioelectronic medicine
BIOS Health is a neural engineering company developing an AI-powered platform that reads and interprets peripheral nervous system signals in real time. Its technology links nerve activity to physiological conditions through the discovery of neural biomarkers, supporting the development of personalised neuromodulation…
Benchtop platform for rapid cell-free protein expression and screening
Nuclera is a Cambridge-based biotechnology company developing benchtop systems for rapid protein expression and screening. Its discovery platform integrates cell-free protein synthesis, digital microfluidics, and automated construct screening to deliver soluble, active proteins in under 48 hours. The system is…
Small molecules improving ribosomal translation accuracy in ageing cells
Ribogenyx is a biotechnology company developing small-molecule therapies to improve protein synthesis accuracy in ageing cells. Its approach targets translational fidelity, the accuracy with which ribosomes translate messenger RNA into proteins. By reducing production errors, the company aims to preserve protein…
Managed life science campus near Cambridge with flexible R&D space
Chesterford Research Park is a managed life sciences campus across 250 acres near Little Chesterford, Essex, within the Cambridge research cluster. The park provides flexible laboratory and office space for biotechnology, pharmaceutical and technology companies, with approximately 350,000 sq ft occupied and a…
Multivalent linker technologies for antibody-drug conjugate therapeutics
Spirea is a biopharmaceutical company developing antibody-drug conjugate technologies for targeted cancer treatment. Its multivalent linker platform is designed to attach a wider range of drug payloads to antibodies while enabling higher payload loading and controlled delivery. Spirea conducts preclinical research on…